Cargando…

MASCoD—Multidimensional Assessment of Subjective Cognitive Decline

Subjective cognitive decline (SCD) is a subclinical cognitive impairment that is complained by the individual without being objectively supported at clinical, diagnostic, and neuropsychological levels. It can negatively impact on patient’s frailty and quality of life, as well as on the caregiver’s b...

Descripción completa

Detalles Bibliográficos
Autores principales: Maffoni, Marina, Pierobon, Antonia, Fundarò, Cira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748696/
https://www.ncbi.nlm.nih.gov/pubmed/36533024
http://dx.doi.org/10.3389/fpsyg.2022.921062
_version_ 1784849879592337408
author Maffoni, Marina
Pierobon, Antonia
Fundarò, Cira
author_facet Maffoni, Marina
Pierobon, Antonia
Fundarò, Cira
author_sort Maffoni, Marina
collection PubMed
description Subjective cognitive decline (SCD) is a subclinical cognitive impairment that is complained by the individual without being objectively supported at clinical, diagnostic, and neuropsychological levels. It can negatively impact on patient’s frailty and quality of life, as well as on the caregiver’s burden. Moreover, it can be prodromal to Mild Cognitive Impairment or dementia. Although the clinical manifestations of SCD can differ along with several cognitive domains, to date there are only screening tools to investigate subjective memory complaints. Thus, the first aim of this paper is to propose a preliminary English and Italian version of a new screening tool called MASCoD (Multidimensional Assessment of Subjective Cognitive Decline); the second aim is to propose its preliminary adoption on a pilot sample. This schedule is a brief test derived from the review of the literature and the clinical experience provided by an experts panelist. From pilot tests, it seems promising as it can help the professional to make differential diagnosis and to predict the risk of developing severe cognitive impairment over time, developing a personalized care path. This screening tool is brief, easily embeddable in usual clinical assessment, and administrable by different professionals. Furthermore, following validation, it will allow to collect manifold cognitive manifestations of SCD, addressing the shortage of previous validated instruments globally assessing cognition affected by this condition.
format Online
Article
Text
id pubmed-9748696
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97486962022-12-15 MASCoD—Multidimensional Assessment of Subjective Cognitive Decline Maffoni, Marina Pierobon, Antonia Fundarò, Cira Front Psychol Psychology Subjective cognitive decline (SCD) is a subclinical cognitive impairment that is complained by the individual without being objectively supported at clinical, diagnostic, and neuropsychological levels. It can negatively impact on patient’s frailty and quality of life, as well as on the caregiver’s burden. Moreover, it can be prodromal to Mild Cognitive Impairment or dementia. Although the clinical manifestations of SCD can differ along with several cognitive domains, to date there are only screening tools to investigate subjective memory complaints. Thus, the first aim of this paper is to propose a preliminary English and Italian version of a new screening tool called MASCoD (Multidimensional Assessment of Subjective Cognitive Decline); the second aim is to propose its preliminary adoption on a pilot sample. This schedule is a brief test derived from the review of the literature and the clinical experience provided by an experts panelist. From pilot tests, it seems promising as it can help the professional to make differential diagnosis and to predict the risk of developing severe cognitive impairment over time, developing a personalized care path. This screening tool is brief, easily embeddable in usual clinical assessment, and administrable by different professionals. Furthermore, following validation, it will allow to collect manifold cognitive manifestations of SCD, addressing the shortage of previous validated instruments globally assessing cognition affected by this condition. Frontiers Media S.A. 2022-11-30 /pmc/articles/PMC9748696/ /pubmed/36533024 http://dx.doi.org/10.3389/fpsyg.2022.921062 Text en Copyright © 2022 Maffoni, Pierobon and Fundarò. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychology
Maffoni, Marina
Pierobon, Antonia
Fundarò, Cira
MASCoD—Multidimensional Assessment of Subjective Cognitive Decline
title MASCoD—Multidimensional Assessment of Subjective Cognitive Decline
title_full MASCoD—Multidimensional Assessment of Subjective Cognitive Decline
title_fullStr MASCoD—Multidimensional Assessment of Subjective Cognitive Decline
title_full_unstemmed MASCoD—Multidimensional Assessment of Subjective Cognitive Decline
title_short MASCoD—Multidimensional Assessment of Subjective Cognitive Decline
title_sort mascod—multidimensional assessment of subjective cognitive decline
topic Psychology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748696/
https://www.ncbi.nlm.nih.gov/pubmed/36533024
http://dx.doi.org/10.3389/fpsyg.2022.921062
work_keys_str_mv AT maffonimarina mascodmultidimensionalassessmentofsubjectivecognitivedecline
AT pierobonantonia mascodmultidimensionalassessmentofsubjectivecognitivedecline
AT fundarocira mascodmultidimensionalassessmentofsubjectivecognitivedecline